Results 21 to 30 of about 252,964 (178)

Multidrug-resistant Tuberculosis Burden among the New Tuberculosis Patients in Zhejiang Province: An Observational Study, 2009–2013

Chinese Medical Journal, 2017
Background: Screening on multidrug-resistant tuberculosis (MDR-TB) has been limited to the serious TB subpopulations excluding the new TB patients. This study aimed to examine MDR-TB burden among the new TB patients.
Ying Peng, Song-Hua Chen, Le Zhang, Bin Chen, Ming-Wu Zhang, Tie-Niu He, Fei Wang, Cheng-Liang Chai, Lin Zhou, Yu Zhang, Xiao-Meng Wang, Zhongwei Jia   +11 more
doaj   +1 more source

Rising challenge of multidrug-resistant tuberculosis in China: a predictive study using Markov modeling

Infectious Diseases of Poverty, 2020
Background Multidrug-resistant tuberculosis (MDR-TB) is on the rise in China. This study used a dynamic Markov model to predict the longitudinal trends of MDR-TB in China by 2050 and to assess the effects of alternative control measures.
Bing-Ying Li, Wen-Pei Shi, Chang-Ming Zhou, Qi Zhao, Vinod K Diwan, Xu-Bin Zheng, Yang Li, Sven Hoffner, Biao Xu   +8 more
doaj   +1 more source

Screening and identification of differentially expressed long non-coding RNAs in multidrug-resistant tuberculosis [PDF]

PeerJ, 2022
Background Efforts to eradicate tuberculosis are largely threatened by drug-resistant tuberculosis, particularly, multidrug-resistant tuberculosis (MDR-TB).
Junwei Zhao, ShuHui Gao, Chunguang Chen, Hui Li, Shaohua Wang, Yongmin Yu, Liang Ming   +6 more
doaj   +2 more sources

PEMETAAN KASUS MULTIDRUG RESISTANT TUBERCULOSIS(MDR-TB) DI KALIMANTAN BARAT [PDF]

, 2021
Penyakit Tuberkulosis (TB) masih menjadi prioritas utama di dunia dan menjadi salah satu target dalam SDGs (Sustainability Development Goals). Pengobatan TB yang tidak memadai dapat meningkatkan risiko resistansi kuman terhadap Obat Anti TB (OAT), salah ...
Debataraja, Naomi Nessyana, Yudhi, Yudhi, Septiani, Zettira   +2 more
core   +1 more source

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy

Journal of Market Access & Health Policy, 2017
Objective: To evaluate the cost-effectiveness of bedaquiline plus background drug regimens (BR) for multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) in Italy.
Luigi R. Codecasa, Mondher Toumi, Anna D’Ausilio, Andrea Aiello, Francesco Damele, Roberta Termini, Alessia Uglietti, Robert Hettle, Giorgio Graziano, Saverio De Lorenzo   +9 more
doaj   +1 more source

Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa [PDF]

, 2013
South Africa shows one of the highest global burdens of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB). Since 2002, MDR-TB in South Africa has been treated by a standardized combination therapy, which until 2010 included
Pillay, Manormoney, van Helden, Paul D., Nicolaas C. Gey van Pittius (173264), Paul D. van Helden (33594), Marlein E Bosman, Gagneux, Sebastien, Thomas C Victor, Manormoney Pillay (257769), Nicolaas C Gey van Pittius, Borna Müller (173253), Hayes, Cindy, Streicher, Elizabeth M., Andre Trollip (449922), Robin M Warren, Elizabeth M Streicher, Trollip, Andre, Violet N. Chihota (143307), Warren, Robin M., Bosman, Marlein E., Müller, Borna, Violet N Chihota, Cindy Hayes, Marisa Klopper (398815), Cindy Hayes (449923), Elizabeth M. Streicher (439727), Borna Müller, Paul D van Helden, Marlein E. Bosman (449924), Klopper, Marisa, Gerrit Coetzee, Sebastien Gagneux (149824), Chihota, Violet N., Andre Trollip, Marisa Klopper, Sebastien Gagneux, Gerrit Coetzee (296078), Victor, Thomas C., Manormoney Pillay, Coetzee, Gerrit, Gey van Pittius, Nicolaas C., Robin M. Warren (33593), Thomas C. Victor (185348), Pillay M, Klopper Marisa, Warren Robin M., van Helden PD, Trollip A, Streicher EM, Victor Thomas C., Coetzee Gerrit, Gey van Pittius NC, Chihota VN, Müller Borna, Warren RM, Hayes C, Gagneux Sebastien, Gagneux S, Streicher Elizabeth M., Trollip Andre, Müller B, Coetzee G, Gey van Pittius Nicolaas C., Bosman Marlein E., Pillay Manormoney, Chihota Violet N., van Helden Paul D., Victor TC, Hayes Cindy, Bosman ME, Klopper M   +69 more
core   +2 more sources

Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM) : study protocol for a randomized controlled trial [PDF]

, 2014
Background In contrast to drug-sensitive tuberculosis, the guidelines for the treatment of multi-drug-resistant tuberculosis (MDR-TB) have a very poor evidence base; current recommendations, based on expert opinion, are that patients should be treated ...
Squire, Stephen Bertel, Squire, S Bertel, Patrick PJ Phillips, Madan, Jason, Rusen, I. D., Chiang, Chen-Yuan, Armand Van Deun, Chiang, Chen Yuan, Gabriela Torrea, Phillips, P. (Patrick), Van Deun, Armand, Rusen, ID, Meredith, Sarah K, Jason Madan, Meredith, Sarah K., Nunn, Andrew J, ID Rusen, Nunn, Andrew J., Squire, Bertie, Torrea, Gabriela, Chen-Yuan Chiang, Sarah K Meredith, Phillips, Patrick PJ, Andrew J Nunn, Phillips, Patrick P.J., S Bertel Squire   +25 more
core   +2 more sources

Comparison of the yield of tuberculosis among contacts of multidrug-resistant and drug-sensitive tuberculosis patients in Ethiopia using GeneXpert as a primary diagnostic test

International Journal of Infectious Diseases, 2018
Objectives: This study compared the yield of tuberculosis (TB) among contacts of multidrug-resistant tuberculosis (MDR-TB) index cases with that in drug-sensitive TB (DS-TB) index cases in a program setting.
Nebiyu Hiruy, Muluken Melese, Dereje Habte, Degu Jerene, Zewdu Gashu, Genetu Alem, Ilili Jemal, Belay Tessema, Beza Belayneh, Pedro G. Suarez   +9 more
doaj   +1 more source

Microbiome in sputum as a potential biomarker of chronicity in pulmonary resistant to rifampicin-tuberculosis and multidrug-resistant-tuberculosis patients

International Journal of Mycobacteriology, 2021
Background: Cases of tuberculosis (TB) and multidrug-resistant TB (MDR-TB) in South-east Asia including Indonesia are still high. The presence of mixed infections in TB cases has been reported. Several studies revealed the role of the human microbiome in
Nurul Wiqoyah, Ni Made Mertaniasih, Wayan Tunas Artama, Sohkichi Matsumoto   +3 more
doaj   +1 more source

Survival analysis of time to cure on multi-drug resistance tuberculosis patients in Amhara region, Ethiopia

BMC Public Health, 2019
Background Multidrug-resistant tuberculosis (MDR-TB) is caused by bacteria that are resistant to the most effective anti-tuberculosis drug. The MDR-TB is an increasing global problem and the spread of MDR-TB has different recovery time for different ...
Yigzaw Alemu Limenih, Demeke Lakew Workie   +1 more
doaj   +1 more source